Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dellann Elliott Mydland"'
Autor:
Kevin O Lillehei, Steven N Kalkanis, Linda M Liau, Dellann Elliott Mydland, Jeffrey Olson, Nina A Paleologos, Timothy Ryken, Tania Johnson, Evan Scullin
Publikováno v:
CNS Oncology, Vol 7, Iss 2 (2018)
Implantation of biodegradable wafers impregnated with carmustine (BCNU) is one of the few chemotherapeutic modalities that have been evaluated in Phase III trials and approved by the US FDA for treatment of newly diagnosed high-grade glioma and recur
Externí odkaz:
https://doaj.org/article/64f27bf017d94a0c952c42d58d9dc750
Publikováno v:
Patient preference and adherence
Al Musella,1 Ralph DeVitto,2 Matt Anthony,3 Dellann Elliott Mydland4 1The Musella Foundation for Brain Tumor Research & Information, Inc, Hewlett, NY, USA; 2American Brain Tumor Association, Chicago, IL, USA; 3Head for the Cure Foundation, Kansas Cit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca86cdf6c0578ddce2902e7c7e9c2186
https://www.dovepress.com/the-importance-of-shared-decision-making-for-patients-with-glioblastom-peer-reviewed-fulltext-article-PPA
https://www.dovepress.com/the-importance-of-shared-decision-making-for-patients-with-glioblastom-peer-reviewed-fulltext-article-PPA
Autor:
Linda M. Liau, Timothy C. Ryken, Jeffrey J. Olson, Steven N. Kalkanis, Tania Johnson, Nina Paleologos, Evan Scullin, Kevin O. Lillehei, Dellann Elliott Mydland
Publikováno v:
CNS Oncology
CNS oncology, vol 7, iss 2
CNS oncology, vol 7, iss 2
Implantation of biodegradable wafers impregnated with carmustine (BCNU) is one of the few chemotherapeutic modalities that have been evaluated in Phase III trials and approved by the US FDA for treatment of newly diagnosed high-grade glioma and recur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a9778629f6bf496d2ede08e2fe812f
https://doi.org/10.2217/cns-2017-0036
https://doi.org/10.2217/cns-2017-0036